Gufic Biosciences vs Nifty 50: Share Price Performance Compared
- September 25, 2026
- Posted by: Kunal Singla
- Category: Market
Gufic Biosciences share price Rs 422.00 on NSE. Gufic Biosciences vs Nifty 50 over 1 year: +16.72% vs -7.34%. 52-week high Rs 467.80, low Rs 268.00.
Quick Answer
Gufic Biosciences vs Nifty 50 shows Gufic Biosciences ahead of the benchmark on a one-year view, gaining +16.72% against the Nifty 50’s -7.34%. Over the longer term the stock has also stayed ahead of the index, a pattern that reflects its underlying business momentum rather than a single quarter’s swing. Investors comparing the two should also weigh Gufic Biosciences’s trading liquidity, valuation and sector context rather than relying on returns alone.
Gufic Biosciences vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Gufic Biosciences trades on the NSE under the symbol GUFICBIO, and its 1M return of +3.32% compares with the Nifty 50’s -5.22% over the same period.
The Gufic Biosciences vs Nifty 50 comparison matters because Gufic Biosciences is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Gufic Biosciences share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, 3 years, using NSE closing data.
Also read – Godrej Agrovet vs Nifty 50: Share Price Performance Compared
Click Here – Get Free Investment Predictions
Gufic Biosciences vs Nifty 50: Performance at a Glance
The table below sets out Gufic Biosciences vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 25 September 2026.
| Time Frame | Gufic Biosciences Return | Nifty 50 Return | Difference |
|---|---|---|---|
| 1 Month | +3.32% | -5.22% | +8.54% pp |
| 3 Months | +16.69% | -4.13% | +20.81% pp |
| 6 Months | +50.47% | -1.04% | +51.52% pp |
| 1 Year | +16.72% | -7.34% | +24.06% pp |
| 3 Years | +45.42% (Gufic Biosciences) | +17.22% (Nifty 50) | +28.19% pp |
On the Gufic Biosciences vs Nifty 50 scorecard, Gufic Biosciences has stayed ahead of the index over the most recent one-year window. Over the longer term the stock has also stayed ahead of the index, a pattern that reflects its underlying business momentum rather than a single quarter’s swing.
Check the Univest Screener for live Gufic Biosciences and Nifty 50 data
Why the Gufic Biosciences vs Nifty 50 Gap Exists
Gufic Biosciences’s stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Gufic Biosciences vs Nifty 50 return table above.
A second factor behind the Gufic Biosciences vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Gufic Biosciences’s price sharply in either direction over short periods, while the Nifty 50’s return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock’s swings.
Download the Univest iOS App or Univest Android App to track Gufic Biosciences and Nifty 50 live on the go.
Gufic Biosciences vs Nifty 50: Has Gufic Biosciences Beaten the Benchmark?
Gufic Biosciences has beaten the Nifty 50 over the past year, gaining +16.72% against the index’s -7.34% over the same period.
Also read – Goodluck India vs Nifty 50: Share Price Performance Compared
Risks of the Gufic Biosciences vs Nifty 50 Comparison
Reading too much into a Gufic Biosciences vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Gufic Biosciences carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50’s more liquid, blended profile. A stock’s 52-week range of Rs 268.00 to Rs 467.80 also shows the kind of volatility that a single-stock investment carries relative to a broad index.
Conclusion
Gufic Biosciences vs Nifty 50 highlights how a single stock’s return path can differ from a diversified benchmark over different time horizons. Investors weighing the Gufic Biosciences vs Nifty 50 record should factor in Gufic Biosciences’s volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Has Gufic Biosciences outperformed the Nifty 50 in the last year?
Ans. Yes. Gufic Biosciences gained +16.72% over the past year while the Nifty 50 returned -7.34% over the same period, based on NSE closing prices to 25 September 2026.
How does Gufic Biosciences vs Nifty 50 look over 3 years?
Ans. Over three years Gufic Biosciences has returned +45.42% compared with the Nifty 50’s +17.22%, so in the Gufic Biosciences vs Nifty 50 comparison the stock has been ahead over this horizon.
What is the Gufic Biosciences share price today compared to Nifty 50?
Ans. Gufic Biosciences share price stood at Rs 422.00 on NSE, while the Nifty 50 traded at 23,063.10 based on the same closing data window.
What is the 52-week high and low of Gufic Biosciences?
Ans. Gufic Biosciences’s 52-week high is Rs 467.80 and its 52-week low is Rs 268.00, based on NSE data.
Why does Gufic Biosciences show bigger price swings than the Nifty 50?
Ans. Gufic Biosciences carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Gufic Biosciences’s price more sharply than the diversified index, a key reason the Gufic Biosciences vs Nifty 50 return gap varies across time frames.
Is Gufic Biosciences a good long-term investment compared to a Nifty 50 index fund?
Ans. Gufic Biosciences’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Gufic Biosciences vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.